Mavenclad pulls double duty for MS, other autoimmune conditions
In addition to controlling multiple sclerosis (MS), the approved therapy Mavenclad (cladribine) may also help manage certain coexisting…
Online GLP-1 prescriptions filled in minutes, no doctor required, Yale study finds
Most websites dispensing GLP-1 prescriptions are shipping generic knockoffs the same day without contacting patients’ doctors or screening…
Why Everyone’s Turning to Minoxidil for Hair Growth
For one, it can prolong the hair’s growth phase. While the exact mechanism isn’t entirely understood, “it’s thought…
Heatwaves can damage your medication. Here’s how to protect it
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
The FDA at 120: A Long, Distinguished History Protecting Americans
Image By: Kyle A. Diamantas, J.D., Acting Commissioner of Food and Drugs Kyle A. Diamantas, J.D. There may…
GLP-1 trials reveal diet quality gap as companion products boom
Many GLP-1 clinical trials are not tracking what patients are consuming, pointing to a gap in the weight-loss…
Better Growth Buy: Axsome vs Revolution Medicines
Axsome Therapeutics (NASDAQ: AXSM) and Revolution Medicines (NASDAQ: RVMD) have offered investors significant growth so far this year.…
Cincinnati poison control expert shares concerns about social media ‘Benadryl challenge’
A social media trend called the “Benadryl challenge” is raising concerns in Ohio as it encourages teenagers to…
Wolverhampton online medicine racket put ‘profit before safety’
Four people have been sentenced for illegally selling prescription medicines online across the UK. Three men and a…
Ozempic Lawsuits 2026: Side Effects & $2B Claims
Ozempic Lawsuits 2026: Side Effects & $2B Claims | Image by Radoslaw Maciejewski/Shutterstock A surge in demand for…
US FDA approves kidney disease drug
The United States Food and Drug Administration (US FDA) has approved Trutakna (atacicept-vymj), a first-in-class treatment developed by…
Short-term savings, long-term costs: what cuts to medicines optimisation teams could mean for the NHS
In March 2025, then health secretary Wes Streeting announced a swathe of NHS reforms. Among these was a mandate…